357 related articles for article (PubMed ID: 34063186)
1. Immunotherapy and Gene Therapy for Oncoviruses Infections: A Review.
de Almeida NAA; Ribeiro CRA; Raposo JV; de Paula VS
Viruses; 2021 May; 13(5):. PubMed ID: 34063186
[TBL] [Abstract][Full Text] [Related]
2. The implication of CRISPR/Cas9 genome editing technology in combating human oncoviruses.
Gilani U; Shaukat M; Rasheed A; Shahid M; Tasneem F; Arshad M; Rashid N; Shahzad N
J Med Virol; 2019 Jan; 91(1):1-13. PubMed ID: 30133783
[TBL] [Abstract][Full Text] [Related]
3. Human oncoviruses: Mucocutaneous manifestations, pathogenesis, therapeutics, and prevention: Hepatitis viruses, human T-cell leukemia viruses, herpesviruses, and Epstein-Barr virus.
Mui UN; Haley CT; Vangipuram R; Tyring SK
J Am Acad Dermatol; 2019 Jul; 81(1):23-41. PubMed ID: 30502415
[TBL] [Abstract][Full Text] [Related]
4. Retroviral Vectors for Cancer Gene Therapy.
Schambach A; Morgan M
Recent Results Cancer Res; 2016; 209():17-35. PubMed ID: 28101685
[TBL] [Abstract][Full Text] [Related]
5. [Application of clustered regularly interspaced short palindromic repeats- associated protein 9 gene editing technology for treatment of HBV infection].
Wang YD; Liang QF; Li ZY; Zhao CY
Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):860-864. PubMed ID: 30616324
[TBL] [Abstract][Full Text] [Related]
6. Human oncoviruses: Mucocutaneous manifestations, pathogenesis, therapeutics, and prevention: Papillomaviruses and Merkel cell polyomavirus.
Haley CT; Mui UN; Vangipuram R; Rady PL; Tyring SK
J Am Acad Dermatol; 2019 Jul; 81(1):1-21. PubMed ID: 30502418
[TBL] [Abstract][Full Text] [Related]
7. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
Mashimo T
Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic viruses as emerging therapy against cancers including Oncovirus-induced cancers.
Seyed-Khorrami SM; Soleimanjahi H; Łos MJ; Zandi K; Emameh RZ
Eur J Pharmacol; 2023 Jan; 939():175393. PubMed ID: 36435236
[TBL] [Abstract][Full Text] [Related]
9. [CRISPR/Cas9 technology in disease research and therapy: a review].
Shi M; Shen Z; Zhang N; Wang L; Yu C; Yang Z
Sheng Wu Gong Cheng Xue Bao; 2021 Apr; 37(4):1205-1228. PubMed ID: 33973436
[TBL] [Abstract][Full Text] [Related]
10. The Role of Viruses in Carcinogenesis and Molecular Targeting: From Infection to Being a Component of the Tumor Microenvironment.
Dzobo K
OMICS; 2021 Jun; 25(6):358-371. PubMed ID: 34037476
[TBL] [Abstract][Full Text] [Related]
11. Targeted genome editing tools for disease modeling and gene therapy.
Cai M; Yang Y
Curr Gene Ther; 2014 Feb; 14(1):2-9. PubMed ID: 24665839
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
[TBL] [Abstract][Full Text] [Related]
13. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
Eid A; Mahfouz MM
Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
[TBL] [Abstract][Full Text] [Related]
15. [Genome-editing: focus on the off-target effects].
He X; Gu F
Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1757-1775. PubMed ID: 29082723
[TBL] [Abstract][Full Text] [Related]
16. Gene editing in dermatology: Harnessing CRISPR for the treatment of cutaneous disease.
Baker C; Hayden MS
F1000Res; 2020; 9():281. PubMed ID: 32528662
[TBL] [Abstract][Full Text] [Related]
17. Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Gene Editing Technique in Xenotransplantation.
Naeimi Kararoudi M; Hejazi SS; Elmas E; Hellström M; Naeimi Kararoudi M; Padma AM; Lee D; Dolatshad H
Front Immunol; 2018; 9():1711. PubMed ID: 30233563
[TBL] [Abstract][Full Text] [Related]
18. Genome-Editing Technologies: Principles and Applications.
Gaj T; Sirk SJ; Shui SL; Liu J
Cold Spring Harb Perspect Biol; 2016 Dec; 8(12):. PubMed ID: 27908936
[TBL] [Abstract][Full Text] [Related]
19. TRIM5α Degradation via Autophagy Is Not Required for Retroviral Restriction.
Imam S; Talley S; Nelson RS; Dharan A; O'Connor C; Hope TJ; Campbell EM
J Virol; 2016 Jan; 90(7):3400-10. PubMed ID: 26764007
[TBL] [Abstract][Full Text] [Related]
20. Using Gene Editing Approaches to Fine-Tune the Immune System.
Pavlovic K; Tristán-Manzano M; Maldonado-Pérez N; Cortijo-Gutierrez M; Sánchez-Hernández S; Justicia-Lirio P; Carmona MD; Herrera C; Martin F; Benabdellah K
Front Immunol; 2020; 11():570672. PubMed ID: 33117361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]